| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |